BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Fisher Scientific International Inc.'s (FSH) Second-Quarter Sales And Earnings Reach All-Time High; Company Completes Acquisition Of McKesson BioServices (MCK) And Announces Acquisitions Of Lancaster Laboratories And Cellomics, Inc.


10/19/2005 5:09:05 PM

HAMPTON, N.H.--(BUSINESS WIRE)--Aug. 3, 2005--Fisher Scientific International Inc. (NYSE: FSH), a world leader in serving science, today reported record sales and earnings for the second quarter ended June 30, 2005, reflecting strong demand from healthcare customers and continued growth in sales of scientific products and services. "We concluded the first half of the year on a strong note -- setting new records for both sales and earnings," said Paul M. Montrone, chairman and chief executive officer. "Our scientific research and healthcare business segments performed well, and our integration of the Apogent businesses is on track. In addition to the acquisition of McKesson BioServices, which we completed last week, we have signed definitive agreements to acquire two other companies that will further expand our pharmaceutical service offering and enhance our portfolio of products for the life-science marketplace."

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES